Assignee
ZHEJIANG YANGLI PHARMACEUTICAL TECH CO LTD
CN·4 granted patents·2 pending applications·0 citations·filing 2021–2025
Top patents by PatentIndex Score
6 records- 0165US12410155B2Salt form and crystal form of tetrahydrocyclohepta indazole compoundZHEJIANG YANGLI PHARMACEUTICAL TECH CO LTD·Filed 2022·Granted Sep 9, 2025·0 cites·17 claims
- 0262US2025361240A1Pyranopyridine compound, process for preparing the same, pharmaceutical composition and use thereofZHEJIANG YANGLI PHARMACEUTICAL TECH CO LTD·Filed 2025·Application pending·0 cites
- 0356US12577246B2Indoline compoundZHEJIANG YANGLI PHARMACEUTICAL TECH CO LTD·Filed 2022·Granted Mar 17, 2026·0 cites·19 claims
- 0454US12435101B2Isochroman compoundZHEJIANG YANGLI PHARMACEUTICAL TECH CO LTD·Filed 2021·Granted Oct 7, 2025·0 cites·14 claims
- 0552US12415799B2Indazole-fused cyclic compoundZHEJIANG YANGLI PHARMACEUTICAL TECH CO LTD·Filed 2021·Granted Sep 16, 2025·0 cites·11 claims
- 0650US2025171474A1Crystal form of isochroman compoundZHEJIANG YANGLI PHARMACEUTICAL TECH CO LTD·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ZHEJIANG YANGLI PHARMACEUTICAL TECH CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →